Inderpal Singh
General Counsel chez IMMUNIC, INC.
Profil
Inderpal Singh is currently the General Counsel at Immunic, Inc. Prior to this, he worked as the Head of Biopharma at Sandoz International GmbH from 2018 to 2021, Head of Global Manufacturing at Merck KGaA from 2015 to 2017, and Legal Director-Europe Division at Biogen International GmbH from 2013 to 2015.
Singh holds an MBA from both the University of Mannheim and Insead Business School.
Postes actifs de Inderpal Singh
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | General Counsel | 01/06/2021 |
Anciens postes connus de Inderpal Singh
| Sociétés | Poste | Fin |
|---|---|---|
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01/06/2021 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2017 |
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Corporate Officer/Principal | 01/01/2015 |
Formation de Inderpal Singh
| University of Mannheim | Masters Business Admin |
| Insead Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Health Technology |
